- Home
- FCNCP vs MDCX Comparison
FCNCP vs MDCX Comparison
Compare FCNCP & MDCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | FCNCP | MDCX |
|---|---|---|
| Founded | N/A | 2008 |
| Country | United States | United States |
| Employees | 18141 | 16 |
| Industry | Major Banks | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 16.6M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | FCNCP | MDCX |
|---|---|---|
| Price | $20.08 | $0.38 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $14.50 |
| AVG Volume (30 Days) | 7.6K | ★ 1.7M |
| Earning Date | N/A | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $19.97 | $0.25 |
| 52 Week High | $22.86 | $3.69 |
Technical Indicators
Market Signals| Indicator | FCNCP | MDCX |
|---|---|---|
| Relative Strength Index (RSI) | 31.33 | 58.76 |
| Support Level | $20.03 | $0.38 |
| Resistance Level | $21.33 | $0.52 |
| Average True Range (ATR) | 0.23 | 0.03 |
| MACD | -0.03 | 0.01 |
| Stochastic Oscillator | 10.82 | 97.89 |
Price Performance
Historical ComparisonAbout FCNCP First Citizens BancShares Inc.
First Citizens is a US regional bank with total assets of around $236 billion as of March 31, 2026. Headquartered in Raleigh, North Carolina, First Citizens' largest markets are North Carolina, South Carolina, and California. The bank has a track record of acquiring troubled banks from the FDIC, such as Silicon Valley Bridge Bank in 2023, which doubled its asset base. First Citizens offers products and services across retail, commercial, wealth management, and railcar leasing. First Citizens derived over 95% of its earnings from banking and less than 5% from railcar leasing in 2025.
About MDCX Medicus Pharma Ltd.
Medicus Pharma Ltd is a clinical-stage, life sciences, biotech company focused on investing in and accelerating clinical development programs of novel and potentially disruptive therapeutic assets. The company has one operating segment.